Related Experiment Video
Updated: Feb 5, 2026
Author Spotlight: Unraveling the Impact of Mechanical Ventilation on Diaphragm Function and Patient Outcomes
Published on: November 3, 2023
Are stem cells drugs? The regulation of stem cell research and development
1College of Physicians and Surgeons of Columbia University, Department of Pharmacology, 630 W 168 St, PH 7West-321, New York, NY 10032, USA. mrr1@columbia.edu
Abstract:
Stem cell research and its clinical application have become political, social, and medical lightning rods, polarizing opinion among members of the lay community and among medical/scientific professionals. A potpourri of opinion, near-anecdotal observation, and scientifically sound data has sown confusion in ways rarely seen in the medical arts and sciences. A major issue is regulation, with different aspects of stem cell research falling within the purview of different government agencies and local offices. An overarching clearinghouse to review the field and recommend policy is lacking. In the following pages, I touch on the societal framework for regulation, the known and potential risks and benefits of cardiovascular stem cell therapies, whether stem cells should be regulated as drugs or in analogy to drugs, and if there is to be regulation, then by whom. In so doing, I refer to the stem cell literature only as it relates to the discussion of regulation because this is not a review of stem cell research; it is an opinion regarding regulation.
Insights
Stem cell research faces regulatory confusion due to varied opinions and oversight. This analysis explores the societal framework, risks, benefits, and regulatory approaches for cardiovascular stem cell therapies.
Area of Science:
- Biomedical Science
- Regulatory Science
Background:
- Stem cell research and its clinical applications are subjects of intense public and professional debate.
- A lack of a centralized regulatory body creates confusion regarding oversight of stem cell therapies.
Observation:
- Diverse opinions, anecdotal evidence, and scientific data contribute to confusion surrounding stem cell research.
- Current regulation is fragmented, with different agencies overseeing various aspects of stem cell research.
Findings:
- The societal framework for regulation, risks, and benefits of cardiovascular stem cell therapies are discussed.
- The paper examines whether stem cells should be regulated as drugs or analogously to drugs.
Implications:
- Clearer policy recommendations and a unified regulatory approach are needed for stem cell therapies.
- Establishing a dedicated clearinghouse for stem cell research regulation is essential for consistent policy development.
More Related Videos
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 4, 2015
Related Concept Videos
05:51Measuring Diaphragm Thickness and Function Using Point-of-Care Ultrasound
08:47Oral Health Assessment by Lay Personnel for Older Adults
05:17Preparation of High-Quality Fermented Fish Product
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
04:57Proper Care and Cleaning of the Microscope